SE447028B - Bestemning av endstaende sackaridgrupper i glykoprotein - Google Patents
Bestemning av endstaende sackaridgrupper i glykoproteinInfo
- Publication number
- SE447028B SE447028B SE8004815A SE8004815A SE447028B SE 447028 B SE447028 B SE 447028B SE 8004815 A SE8004815 A SE 8004815A SE 8004815 A SE8004815 A SE 8004815A SE 447028 B SE447028 B SE 447028B
- Authority
- SE
- Sweden
- Prior art keywords
- lectin
- glycoprotein
- complex
- labeled
- groups
- Prior art date
Links
- 239000002523 lectin Substances 0.000 claims description 51
- 102000004856 Lectins Human genes 0.000 claims description 50
- 108090001090 Lectins Proteins 0.000 claims description 50
- 108090000288 Glycoproteins Proteins 0.000 claims description 35
- 102000003886 Glycoproteins Human genes 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 28
- 150000001720 carbohydrates Chemical group 0.000 claims description 27
- 239000007790 solid phase Substances 0.000 claims description 8
- 239000012086 standard solution Substances 0.000 claims description 7
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 102000007563 Galectins Human genes 0.000 claims description 3
- 108010046569 Galectins Proteins 0.000 claims description 3
- 101710150766 Sialic acid-binding lectin Proteins 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 claims description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 102000004338 Transferrin Human genes 0.000 description 22
- 108090000901 Transferrin Proteins 0.000 description 22
- 239000012581 transferrin Substances 0.000 description 22
- 239000000499 gel Substances 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 241000239218 Limulus Species 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 241000220457 Crotalaria Species 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 229940072221 immunoglobulins Drugs 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012064 sodium phosphate buffer Substances 0.000 description 3
- KYRUKRFVOACELK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(4-hydroxyphenyl)propanoate Chemical compound C1=CC(O)=CC=C1CCC(=O)ON1C(=O)CCC1=O KYRUKRFVOACELK-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000001948 isotopic labelling Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- WDVIDPRACNGFPP-QWRGUYRKSA-N (2s)-2-[[(2s)-6-amino-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WDVIDPRACNGFPP-QWRGUYRKSA-N 0.000 description 1
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 1
- 101150114104 CROT gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241001529572 Chaceon affinis Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 244000044849 Crotalaria juncea Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 101000766307 Gallus gallus Ovotransferrin Proteins 0.000 description 1
- 241000221931 Hypomyces rosellus Species 0.000 description 1
- 241000239220 Limulus polyphemus Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001302191 Polyphemus Species 0.000 description 1
- 102100023105 Sialin Human genes 0.000 description 1
- 101710105284 Sialin Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 108010009577 asialotransferrins Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002409 microspectrofluorometry Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 125000005630 sialyl group Chemical group 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XREXPQGDOPQPAH-QKUPJAQQSA-K trisodium;[(z)-18-[1,3-bis[[(z)-12-sulfonatooxyoctadec-9-enoyl]oxy]propan-2-yloxy]-18-oxooctadec-9-en-7-yl] sulfate Chemical compound [Na+].[Na+].[Na+].CCCCCCC(OS([O-])(=O)=O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(CCCCCC)OS([O-])(=O)=O)COC(=O)CCCCCCC\C=C/CC(CCCCCC)OS([O-])(=O)=O XREXPQGDOPQPAH-QKUPJAQQSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8004815A SE447028B (sv) | 1980-06-30 | 1980-06-30 | Bestemning av endstaende sackaridgrupper i glykoprotein |
| EP81850116A EP0043359A3 (de) | 1980-06-30 | 1981-06-29 | Bestimmung endständiger Saccharidgruppen in Glycoproteinen |
| PCT/SE1981/000193 WO1982000204A1 (en) | 1980-06-30 | 1981-06-29 | Lectin immunoassay for the determination of terminal saccharide groups in glycoprotein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8004815A SE447028B (sv) | 1980-06-30 | 1980-06-30 | Bestemning av endstaende sackaridgrupper i glykoprotein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8004815L SE8004815L (sv) | 1981-12-31 |
| SE447028B true SE447028B (sv) | 1986-10-20 |
Family
ID=20341326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8004815A SE447028B (sv) | 1980-06-30 | 1980-06-30 | Bestemning av endstaende sackaridgrupper i glykoprotein |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0043359A3 (de) |
| SE (1) | SE447028B (de) |
| WO (1) | WO1982000204A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5729949A (en) * | 1980-07-30 | 1982-02-18 | Nippon Koutai Kenkyusho:Kk | Determination of sugar branch related to cancer and diagnostic technique of cancer |
| US5126243A (en) * | 1982-08-09 | 1992-06-30 | Centocor, Inc. | Immunoassay for carbohydrate antigenic determinant |
| US4629692A (en) * | 1982-12-06 | 1986-12-16 | Miles Laboratories, Inc. | Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia |
| US4783420A (en) * | 1984-04-06 | 1988-11-08 | Centocor, Inc. | Immunoassay for carbohydrate antigenic determinant |
| FI852545A7 (fi) * | 1984-06-29 | 1985-12-30 | Ortho Diagnostic Systems Inc | Vasta-aine-lektiini kerrosanalyysi. |
| US4659659A (en) * | 1985-01-22 | 1987-04-21 | Monsanto Company | Diagnostic method for diseases having an arthritic component |
| US5443956A (en) * | 1985-01-29 | 1995-08-22 | Oncogene Science, Inc. | Detection, quantitation and classification of RAS proteins in body fluids and tissues |
| US6200764B1 (en) | 1985-01-29 | 2001-03-13 | Bayer Corporation | Detection, quantitation and classification of ras proteins in body fluids and tissues |
| US5051354A (en) * | 1988-04-15 | 1991-09-24 | Abbott Laboratories | Detection of altered IGA1 in fluid samples |
| DE68929511T2 (de) * | 1988-04-22 | 2004-11-18 | Bayer Corp. | Nachweis, Quantifizierung und Klassifizierung von RAS-Proteinen in Körperflüssigkeiten und Geweben |
| DK626488D0 (da) * | 1988-11-10 | 1988-11-10 | Torben Falck Oerntoft | Fremgangsmaade til udtagning af en sekretproeve via en legemsaabning og til praeparation af proeven med henblik paa kvantitativ bestemmelse af molekylaere strukturer og enzymaktivitet i proeven samt proeveudtagningsindretning til brug derved |
| US5192660A (en) * | 1989-04-24 | 1993-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | ELISA methods for the determination of human platelet derived growth factor (PDGF) dimer forms present in human tissues and fluids |
| EP0605627B1 (de) * | 1991-09-25 | 1999-05-19 | MAKHLOUF, Samar | Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme |
| DE69732121T2 (de) | 1996-10-08 | 2005-12-01 | Alan Zamore | Umwandlung von thermoplastischen zu duroplastischen polymeren durch bestrahlung |
| GB9713559D0 (en) * | 1997-06-26 | 1997-09-03 | Axis Biochemicals Asa | Assay |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2359849A1 (fr) * | 1976-07-27 | 1978-02-24 | Sebia Sa | Procede de preparation de films rehydratables d'agarose ou de gelose contenant des anticorps pour les techniques immunochimiques |
| US4371515A (en) * | 1978-12-26 | 1983-02-01 | E-Y Laboratories, Inc. | Method for forming an isolated lectin-immunological conjugate |
| US4289747A (en) * | 1978-12-26 | 1981-09-15 | E-Y Laboratories, Inc. | Immunological determination using lectin |
| DK36980A (da) * | 1979-01-30 | 1980-07-31 | Otsuka Pharma Co Ltd | Fremgangsmaade til bestemmelse af tumorforbundet glycobindingsholdigt stof og diagnosticering af cancer |
| DE3070194D1 (en) * | 1979-04-16 | 1985-03-28 | Massachusetts Inst Technology | An in vitro method for determining malignancy in mammalian tissue |
| DE3003352A1 (de) * | 1980-01-31 | 1981-08-06 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von eisenoxidbelegten metallpigmenten |
-
1980
- 1980-06-30 SE SE8004815A patent/SE447028B/sv not_active IP Right Cessation
-
1981
- 1981-06-29 WO PCT/SE1981/000193 patent/WO1982000204A1/en not_active Ceased
- 1981-06-29 EP EP81850116A patent/EP0043359A3/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1982000204A1 (en) | 1982-01-21 |
| EP0043359A2 (de) | 1982-01-06 |
| EP0043359A3 (de) | 1982-01-20 |
| SE8004815L (sv) | 1981-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE447028B (sv) | Bestemning av endstaende sackaridgrupper i glykoprotein | |
| CA1235118A (en) | Assay for qualitatively and/or quantitatively measuring hlh or hcg body fluids and reagents therefor | |
| Beyer et al. | Quantitation of two endogenous lactose-inhibitable lectins in embryonic and adult chicken tissues. | |
| CA1145672A (en) | Polyethylene glycol in double antibody radioimmunoassay | |
| Lalloz et al. | Hyperthyroxinaemia: abnormal binding of T4 by an inherited albumin variant | |
| US4088746A (en) | Radioimmunoassay for thyroid-stimulating hormone (TSH) | |
| Marshall et al. | Studies on human thyroxine-binding globulin (TBG): I. Purification of TBG and immunologic studies on the relationship between TBG from normal persons and those with TBG “deficiency” | |
| Nachbar et al. | Interactions of lectins with plasma membrane glycoproteins of the Ehrlich ascites carcinoma cell | |
| EP0283779B1 (de) | Verfahren zur Bestimmung von hochmolekularen Hyaluronsäure | |
| US4824777A (en) | Method for determining thyroxine uptake | |
| Glad et al. | Immunocapillarymigration with enzyme-labeled antibodies: rapid quantification of C-reactive protein in human plasma | |
| KOBAYASHI et al. | Evaluation of the method of insulin binding studies in human erythrocytes | |
| Waldhäusl et al. | Determination of aldosterone by Sephadex LH-20 chromatography and radioimmunoassay | |
| Schmid et al. | Radioimmunological determination of myelin basic protein (MBP) and MBP-antibodies | |
| Hamilton et al. | Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays | |
| Gonyea | Purification and iodination of antibody for use in an immunoradiometric assay for serum ferritin. | |
| US4223002A (en) | Isolation of alpha1 -fetoprotein | |
| Rush et al. | Solid-phase radioimmunoassay on polystyrene beads and its application to dopamine-β-hydroxylase | |
| US3867518A (en) | Radioimmunoassay for insulin | |
| Tai et al. | Localization of the metal-induced conformational transition of bovine prothrombin. | |
| US4096237A (en) | Immunoassay for β-endorphin | |
| Natali et al. | Isolation of soluble immune complexes from serum using protein A bearing Staphylococcus aureus bacteria: separation of the antigen from immune complex and production of antisera | |
| JPS5856696A (ja) | カラムを用いる酵素免疫測定法 | |
| Stein et al. | Picogram measurement of prostaglandin E2 synthesis by gastric mucosa by high-performance liquid chromatography | |
| US4195073A (en) | Radioimmunoassay of alpha 1 fetoprotein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8004815-0 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8004815-0 Format of ref document f/p: F |